InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Sullivan Ryan T. Director active across 1 company, notably Anacor Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been published. Breakdown: 0 buy · 3 sells. Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations